IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production

Biochem Biophys Res Commun. 1996 Nov 12;228(2):611-5. doi: 10.1006/bbrc.1996.1705.

Abstract

TNF alpha and IL-1 beta have previously been shown to increase the IGFBP-1 concentration in plasma and liver under in vivo conditions. The present study demonstrates that another inflammatory cytokine, IL-6, also elevates a 30- to 32-kDa IGF binding protein in the plasma of mice. Moreover, IL-6 produced dose- and time-dependent increases in IGFBP-1 production by HepG2 cells. The maximal IL-6-induced increase in IGFBP-1 was comparable to that observed with dexamethasone, and this increase was attenuated by diltiazem or dantrolene, both of which are known to reduce the cytosolic Ca2+ concentration. Finally, incubation of HepG2 cells with TNF alpha or IL-1 beta also increased IGFBP-1 in a dose-dependent manner. These results demonstrate that IGFBP-1 production is mediated directly by proinflammatory cytokines and suggest that this mechanism may be important for the upregulation of IGFBP-1 seen in catabolic conditions associated with overexpression of these cytokines.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Line
  • Dantrolene / pharmacology
  • Diltiazem / pharmacology
  • Dose-Response Relationship, Drug
  • Endotoxins / pharmacology
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 / biosynthesis*
  • Insulin-Like Growth Factor Binding Protein 1 / blood
  • Interleukin-6 / pharmacology*
  • Kinetics
  • Male
  • Mice
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Endotoxins
  • Insulin-Like Growth Factor Binding Protein 1
  • Interleukin-6
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Diltiazem
  • Dantrolene